Global Prostate Cancer Drugs Market Size, Status and Forecast 2022

Global Prostate Cancer Drugs Market Size, Status and Forecast 2022

1 Industry Overview of Prostate Cancer Drugs

1.1 Prostate Cancer Drugs Market Overview

1.1.1 Prostate Cancer Drugs Product Scope

1.1.2 Market Status and Outlook

1.2 Global Prostate Cancer Drugs Market Size and Analysis by Regions

1.2.1 United States

1.2.2 EU

1.2.3 Japan

1.2.4 China

1.2.5 India

1.2.6 Southeast Asia

1.3 Prostate Cancer Drugs Market by Type

1.3.1 Hormonal Therapy

1.3.2 Chemotherapy

1.3.3 Immunotherapy

1.3.4 Targeted Therapy

1.4 Prostate Cancer Drugs Market by End Users/Application

1.4.1 Clinics

1.4.2 Hospitals

2 Global Prostate Cancer Drugs Competition Analysis by Players

2.1 Prostate Cancer Drugs Market Size (Value) by Players (2016 and 2017)

2.2 Competitive Status and Trend

2.2.1 Market Concentration Rate

2.2.2 Product/Service Differences

2.2.3 New Entrants

2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles

3.1 AbbVie

3.1.1 Company Profile

3.1.2 Main Business/Business Overview

3.1.3 Products, Services and Solutions

3.1.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)

3.1.5 Recent Developments

3.2 Astellas Pharma

3.2.1 Company Profile

3.2.2 Main Business/Business Overview

3.2.3 Products, Services and Solutions

3.2.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)

3.2.5 Recent Developments

3.3 Astra Zeneca

3.3.1 Company Profile

3.3.2 Main Business/Business Overview

3.3.3 Products, Services and Solutions

3.3.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)

3.3.5 Recent Developments

3.4 Johnson & Johnson

3.4.1 Company Profile

3.4.2 Main Business/Business Overview

3.4.3 Products, Services and Solutions

3.4.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)

3.4.5 Recent Developments

3.5 Sanofi

3.5.1 Company Profile

3.5.2 Main Business/Business Overview

3.5.3 Products, Services and Solutions

3.5.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)

3.5.5 Recent Developments

3.6 GlaxoSmithKline

3.6.1 Company Profile

3.6.2 Main Business/Business Overview

3.6.3 Products, Services and Solutions

3.6.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)

3.6.5 Recent Developments

3.7 Merck Group

3.7.1 Company Profile

3.7.2 Main Business/Business Overview

3.7.3 Products, Services and Solutions

3.7.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)

3.7.5 Recent Developments

3.8 Novartis

3.8.1 Company Profile

3.8.2 Main Business/Business Overview

3.8.3 Products, Services and Solutions

3.8.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)

3.8.5 Recent Developments

3.9 Amgen

3.9.1 Company Profile

3.9.2 Main Business/Business Overview

3.9.3 Products, Services and Solutions

3.9.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)

3.9.5 Recent Developments

3.10 Bayer HealthCare

3.10.1 Company Profile

3.10.2 Main Business/Business Overview

3.10.3 Products, Services and Solutions

3.10.4 Prostate Cancer Drugs Revenue (Value) (2012-2017)

3.10.5 Recent Developments

3.11 Ferring Pharmaceutical

3.12 Janssen Pharmaceuticals

3.13 Endo Pharmaceuticals

3.14 BMS

3.15 Takeda Pharmaceuticals

3.16 Northwest Biotherapeutics

3.17 Teva Pharmaceutical

3.18 Boehringer Ingelheim

3.19 Foresee Pharmaceuticals

3.20 Tokai Pharmaceuticals

3.21 Spectrum Pharmaceuticals

4 Global Prostate Cancer Drugs Market Size by Type and Application (2012-2017)

4.1 Global Prostate Cancer Drugs Market Size by Type (2012-2017)

4.2 Global Prostate Cancer Drugs Market Size by Application (2012-2017)

4.3 Potential Application of Prostate Cancer Drugs in Future

4.4 Top Consumer/End Users of Prostate Cancer Drugs

5 United States Prostate Cancer Drugs Development Status and Outlook

5.1 United States Prostate Cancer Drugs Market Size (2012-2017)

5.2 United States Prostate Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Prostate Cancer Drugs Development Status and Outlook

6.1 EU Prostate Cancer Drugs Market Size (2012-2017)

6.2 EU Prostate Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Prostate Cancer Drugs Development Status and Outlook

7.1 Japan Prostate Cancer Drugs Market Size (2012-2017)

7.2 Japan Prostate Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Prostate Cancer Drugs Development Status and Outlook

8.1 China Prostate Cancer Drugs Market Size (2012-2017)

8.2 China Prostate Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Prostate Cancer Drugs Development Status and Outlook

9.1 India Prostate Cancer Drugs Market Size (2012-2017)

9.2 India Prostate Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Prostate Cancer Drugs Development Status and Outlook

10.1 Southeast Asia Prostate Cancer Drugs Market Size (2012-2017)

10.2 Southeast Asia Prostate Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)

11.1 Global Prostate Cancer Drugs Market Size (Value) by Regions (2017-2022)

11.1.1 United States Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)

11.1.2 EU Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)

11.1.3 Japan Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)

11.1.4 China Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)

11.1.5 India Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)

11.1.6 Southeast Asia Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)

11.2 Global Prostate Cancer Drugs Market Size (Value) by Type (2017-2022)

11.3 Global Prostate Cancer Drugs Market Size by Application (2017-2022)

12 Prostate Cancer Drugs Market Dynamics

12.1 Prostate Cancer Drugs Market Opportunities

12.2 Prostate Cancer Drugs Challenge and Risk

12.2.1 Competition from Opponents

12.2.2 Downside Risks of Economy

12.3 Prostate Cancer Drugs Market Constraints and Threat

12.3.1 Threat from Substitute

12.3.2 Government Policy

12.3.3 Technology Risks

12.4 Prostate Cancer Drugs Market Driving Force

12.4.1 Growing Demand from Emerging Markets

12.4.2 Potential Application

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs Trend/Customer Preference

13.3 External Environmental Change

13.3.1 Economic Fluctuations

13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix

Methodology

Analyst Introduction

Data Source

Figure Prostate Cancer Drugs Product Scope

Figure Global Prostate Cancer Drugs Market Size (Million USD) (2012-2017)

Table Global Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Global Prostate Cancer Drugs Market Share by Regions in 2016

Figure United States Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure EU Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Japan Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure China Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure India Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Southeast Asia Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Global Prostate Cancer Drugs Market Share by Type in 2016

Figure Hormonal Therapy Market Size (Million USD) and Growth Rate (2012-2017)

Figure Chemotherapy Market Size (Million USD) and Growth Rate (2012-2017)

Figure Immunotherapy Market Size (Million USD) and Growth Rate (2012-2017)

Figure Targeted Therapy Market Size (Million USD) and Growth Rate (2012-2017)

Figure Global Prostate Cancer Drugs Market Share by Application in 2016

Figure Prostate Cancer Drugs Market Size (Million USD) and Growth Rate in Clinics (2012-2017)

Figure Prostate Cancer Drugs Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)

Figure Prostate Cancer Drugs Market Size (Million USD) and Growth Rate in Applications 3 (2012-2017)

Table Prostate Cancer Drugs Market Size (Million USD) by Players (2016 and 2017)

Figure Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2016

Figure Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2017

Table AbbVie Basic Information List

Table Prostate Cancer Drugs Business Revenue of AbbVie (2012-2017)

Figure AbbVie Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Astellas Pharma Basic Information List

Table Prostate Cancer Drugs Business Revenue of Astellas Pharma (2012-2017)

Figure Astellas Pharma Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Astra Zeneca Basic Information List

Table Prostate Cancer Drugs Business Revenue of Astra Zeneca (2012-2017)

Figure Astra Zeneca Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Johnson & Johnson Basic Information List

Table Prostate Cancer Drugs Business Revenue of Johnson & Johnson (2012-2017)

Figure Johnson & Johnson Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Sanofi Basic Information List

Table Prostate Cancer Drugs Business Revenue of Sanofi (2012-2017)

Figure Sanofi Prostate Cancer Drugs Business Revenue Market Share in 2016

Table GlaxoSmithKline Basic Information List

Table Prostate Cancer Drugs Business Revenue of GlaxoSmithKline (2012-2017)

Figure GlaxoSmithKline Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Merck Group Basic Information List

Table Prostate Cancer Drugs Business Revenue of Merck Group (2012-2017)

Figure Merck Group Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Novartis Basic Information List

Table Prostate Cancer Drugs Business Revenue of Novartis (2012-2017)

Figure Novartis Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Amgen Basic Information List

Table Prostate Cancer Drugs Business Revenue of Amgen (2012-2017)

Figure Amgen Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Bayer HealthCare Basic Information List

Table Prostate Cancer Drugs Business Revenue of Bayer HealthCare (2012-2017)

Figure Bayer HealthCare Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Ferring Pharmaceutical Basic Information List

Table Prostate Cancer Drugs Business Revenue of Ferring Pharmaceutical (2012-2017)

Figure Ferring Pharmaceutical Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Janssen Pharmaceuticals Basic Information List

Table Prostate Cancer Drugs Business Revenue of Janssen Pharmaceuticals (2012-2017)

Figure Janssen Pharmaceuticals Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Endo Pharmaceuticals Basic Information List

Table Prostate Cancer Drugs Business Revenue of Endo Pharmaceuticals (2012-2017)

Figure Endo Pharmaceuticals Prostate Cancer Drugs Business Revenue Market Share in 2016

Table BMS Basic Information List

Table Prostate Cancer Drugs Business Revenue of BMS (2012-2017)

Figure BMS Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Takeda Pharmaceuticals Basic Information List

Table Prostate Cancer Drugs Business Revenue of Takeda Pharmaceuticals (2012-2017)

Figure Takeda Pharmaceuticals Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Northwest Biotherapeutics Basic Information List

Table Prostate Cancer Drugs Business Revenue of Northwest Biotherapeutics (2012-2017)

Figure Northwest Biotherapeutics Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Teva Pharmaceutical Basic Information List

Table Prostate Cancer Drugs Business Revenue of Teva Pharmaceutical (2012-2017)

Figure Teva Pharmaceutical Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Boehringer Ingelheim Basic Information List

Table Prostate Cancer Drugs Business Revenue of Boehringer Ingelheim (2012-2017)

Figure Boehringer Ingelheim Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Foresee Pharmaceuticals Basic Information List

Table Prostate Cancer Drugs Business Revenue of Foresee Pharmaceuticals (2012-2017)

Figure Foresee Pharmaceuticals Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Tokai Pharmaceuticals Basic Information List

Table Prostate Cancer Drugs Business Revenue of Tokai Pharmaceuticals (2012-2017)

Figure Tokai Pharmaceuticals Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Spectrum Pharmaceuticals Basic Information List

Table Prostate Cancer Drugs Business Revenue of Spectrum Pharmaceuticals (2012-2017)

Figure Spectrum Pharmaceuticals Prostate Cancer Drugs Business Revenue Market Share in 2016

Table Global Prostate Cancer Drugs Market Size (Million USD) by Type (2012-2017)

Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2012

Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2013

Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2014

Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2015

Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2016

Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2017

Table Global Prostate Cancer Drugs Market Size (Million USD) by Application (2012-2017)

Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2012

Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2013

Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2014

Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2015

Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2016

Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2017

Table Top Consumer/End Users of Prostate Cancer Drugs

Figure United States Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table United States Prostate Cancer Drugs Market Size (Million USD) by Players (2012-2017)

Figure United States Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2016

Figure United States Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2017

Figure EU Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table EU Prostate Cancer Drugs Market Size (Million USD) by Players (2012-2017)

Figure EU Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2016

Figure EU Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2017

Figure Japan Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table Japan Prostate Cancer Drugs Market Size (Million USD) by Players (2012-2017)

Figure Japan Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2016

Figure Japan Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2017

Figure China Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table China Prostate Cancer Drugs Market Size (Million USD) by Players (2012-2017)

Figure China Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2016

Figure China Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2017

Figure India Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table India Prostate Cancer Drugs Market Size (Million USD) by Players (2012-2017)

Figure India Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2016

Figure India Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2017

Figure Southeast Asia Prostate Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table Southeast Asia Prostate Cancer Drugs Market Size (Million USD) by Players (2012-2017)

Figure Southeast Asia Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2016

Figure Southeast Asia Prostate Cancer Drugs Market Size (Million USD) Share by Players in 2017

Figure Global Prostate Cancer Drugs Market Size (Million USD) (Value) by Regions (2017-2022)

Table Global Prostate Cancer Drugs Market Size (Million USD) by Regions (2017-2022)

Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Regions in 2017

Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Regions in 2022

Figure United States Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)

Figure EU Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)

Figure Japan Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)

Figure China Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)

Figure India Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)

Figure Southeast Asia Prostate Cancer Drugs Revenue and Growth Rate (2017-2022)

Table Global Prostate Cancer Drugs Market Size (Million USD) by Type (2017-2022)

Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2017

Figure Global Prostate Cancer Drugs Market Size (Million USD) Share by Type in 2022

Table Global Prostate Cancer Drugs Market Size (Million USD) by Application (2017-2022)

Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2017

Figure Global Prostate Cancer Drugs Market Size (Million USD) by Application in 2022